The extracellular calcium-sensing receptor is expressed in the cumulus-oocyte complex in mammals and modulates oocyte meiotic maturation.
The extracellular calcium-sensing receptor (CASR) plays an important role in cells involved in calcium (Ca2+) homeostasis by directly sensing changes in the extracellular Ca2+ ion concentration. We previously reported the localization and quantitative expression of CASR protein in human oocytes. In this study, we examined the expression and the functional role of CASR during oocyte meiotic maturation in a large mammal animal model, the horse. As in humans, CASR protein was found to be expressed in equine oocytes and cumulus cells. Western-blot analysis revealed a single 130 kDa band in denuded oocytes and a doublet of 130-120 kDa in cumulus cells. CASR labeling was observed by confocal microscopy in cumulus cells and in oocytes on the plasma membrane and within the cytoplasm at all examined stages of meiosis. Functionally, the CASR allosteric effector NPS R-467, in the presence of 2.92 mM external Ca2+, increased oocyte maturation rate in a dose-dependent manner and its stimulatory effect was attenuated by pre-treatment with the CASR antagonist NPS 2390. NPS R-467 had no effect in suboptimal external Ca2+ (0.5 mM), indicating that it requires higher external Ca2+ to promote oocyte maturation. In oocytes treated with NPS R-467, CASR staining increased at the plasmalemma and was reduced in the cytosol. Moreover, NPS R-467 increased the activity of MAPK, also called ERK, in cumulus cells and oocytes. These results provide evidence of a novel signal transduction pathway modulating oocyte meiotic maturation in mammals in addition to the well-known systemic hormones.
De Santis
Teresa
T
Department of Animal Production, University of Bari, 70010 Valenzano, Bari, Italy.
Casavola
Valeria
V
Reshkin
Stephan Joel
SJ
Guerra
Lorenzo
L
Ambruosi
Barbara
B
Fiandanese
Nadia
N
Dalbies-Tran
Rozenn
R
Goudet
Ghylene
G
Dell'Aquila
Maria Elena
ME
D000218:Adamantane / Q000031:analogs & derivatives / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D054885:Cumulus Cells / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D006736:Horses; D007150:Immunohistochemistry; D008322:Mammals / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D008540:Meiosis / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology*; D009866:Oogenesis / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D011810:Quinoxalines / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D044169:Receptors, Calcium-Sensing / Q000235:genetics* / Q000378:metabolism / Q000502:physiology*; D014018:Tissue Distribution
C569355:2-quinoxaline-carboxamide-N-adamantan-1-yl; D000814:Aniline Compounds; C111654:NPS R-467; D011810:Quinoxalines; D012333:RNA, Messenger; D044169:Receptors, Calcium-Sensing; D000218:Adamantane